CALLUNA PHARMA AS
Clinical stage biotech pioneering antibodies for inflammation and fibrosis.
Overview
- 10
- Employees
- 26.9M NOK
- Revenue
- 2023
- Founded
Key Decision Makers
Susanne Stuffers MD PhD
Board member
Caroline Kurtz
Chief Scientific Officer
Gijs van den Brink MD PhD
Board member
Vincent Loon
Observer to the Board
+8 more contacts in Funnelfeedr
Description
Calluna Pharma is a global biotechnology company specializing in developing therapeutics focused on inflammation and fibrosis. Driven by a lean, committed team, the company is currently in the clinical stage of development. Their innovative approach targets upstream disease amplifiers using first-in...